Skip to main content

Ocular Therapeutix, Inc

OCUL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001393434

In the last 90 days, Ocular Therapeutix, Inc insiders filed 0 open-market purchases and 5 sales; 262 institutions reported holding it in 13F filings for Q2 2026, worth $2.04B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Ocular Therapeutix, Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
5 filings
5 insiders, $333.1K in total
Insiders trading
5
Net value
−$333.1K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Ocular Therapeutix, Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Ocular Therapeutix, Inc
NameTitleLast reported holdingLast filingFilings, past year
Notman DonaldChief Operating Officer366,529Sep 2, 20264
Kaiser PeterChief Development Officer264,378Aug 26, 20266
Nayak SanjayChief Strategy Officer326,898Aug 26, 20266
Heier Jeffrey S.Chief Scientific Officer318,326Aug 26, 20266
Dugel PravinSee Remarks744,903IndirectAug 26, 20267
Raines MerileeDirector60,933Jun 12, 20261
Lindstrom Richard L MDDirector260,933Jun 12, 20262
Graves Adrienne LDirector64,000Jun 12, 20261
Warden Charles MDirector100,464Jun 12, 20261
Williams Leslie J.Director65,433Jun 12, 20261
Hong Seung SuhDirector60,933Jun 12, 20261
Robins Jason ShandChief Financial Officer68,097Jun 12, 20262
Waheed NadiaChief Medical Officer300,079Jun 5, 20264
Robinson David WayneGlobal CCO136,000Jan 26, 20261
Anderman ToddChief Legal Officer152,468Jan 6, 20262
Saroj NamrataChief Business Officer254,620Jan 6, 20262
Meyers Steve LawrenceChief Commercial Officer217,628Jan 6, 20261
Summer Road LLC10% Owner8,591,401IndirectFeb 27, 20240
White Christopher GChief Business Officer123,689Feb 6, 20240
Mattessich Antony C.President and CEO588,701Feb 6, 20240
Ozden Rabia GursesChief Medical Officer153,054Feb 6, 20240
Strassburger Philip C.General Counsel161,493Feb 6, 20240
Goldstein Michael H.President, Ophthalmology & CMO313,335Feb 7, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 2, 2026 (view filing)4:01 PM ETAug 312 daysNotman DonaldChief Operating OfficerSSale−1.10K$10.24−$11.3K−0.3%366.5K after
Aug 26, 2026 (view filing)5:59 PM ETAug 242 daysKaiser PeterChief Development OfficerSSale−3.04K$10.77−$32.7K−1.1%264.4K after10b5-1
Aug 26, 2026 (view filing)5:58 PM ETAug 242 daysNayak SanjayChief Strategy OfficerSSale−1.90K$10.78−$20.4K−0.6%326.9K after10b5-1
Aug 26, 2026 (view filing)5:57 PM ETAug 242 daysHeier Jeffrey S.Chief Scientific OfficerSSale−3.30K$10.78−$35.5K−1.0%318.3K after10b5-1
Aug 26, 2026 (view filing)5:56 PM ETAug 242 daysDugel PravinSee RemarksSSale−21.6K$10.77−$233.2K−0.8%2.53M after10b5-1
Jun 5, 2026 (view filing)Jun 32 daysWaheed NadiaChief Medical OfficerSSale−14.8K$8.27−$122.6K−4.7%300.1K after10b5-1
May 28, 2026 (view filing)May 262 daysDugel PravinSee RemarksSSale−21.2K$8.20−$173.5K−0.8%2.60M after10b5-1
May 28, 2026 (view filing)May 262 daysKaiser PeterChief Development OfficerSSale−2.97K$8.20−$24.3K−1.1%266.1K after10b5-1
May 28, 2026 (view filing)May 262 daysHeier Jeffrey S.Chief Scientific OfficerSSale−3.02K$8.20−$24.7K−0.9%320.4K after10b5-1
May 28, 2026 (view filing)May 262 daysNayak SanjayChief Strategy OfficerSSale−1.86K$8.20−$15.2K−0.6%328.8K after10b5-1
Feb 25, 2026 (view filing)Feb 232 daysDugel PravinSee RemarksSSale−20.1K$8.28−$166.1K−0.7%3.01M after10b5-1
Feb 25, 2026 (view filing)Feb 232 daysKaiser PeterChief Development OfficerSSale−2.81K$8.28−$23.3K−1.0%269.1K after10b5-1
Feb 25, 2026 (view filing)Feb 232 daysHeier Jeffrey S.Chief Scientific OfficerSSale−3.06K$8.28−$25.3K−0.9%323.4K after10b5-1
Feb 25, 2026 (view filing)Feb 232 daysNayak SanjayChief Strategy OfficerSSale−1.76K$8.28−$14.6K−0.5%330.7K after10b5-1
Feb 24, 2026 (view filing)Feb 204 daysWaheed NadiaChief Medical OfficerSSale−3.51K$7.74−$27.2K−1.1%314.9K after10b5-1
Feb 24, 2026 (view filing)Feb 204 daysLindstrom Richard L MDDirectorPPurchase+60.2K$7.66+$461.4K+32.3%246.9K after
Feb 17, 2026 (view filing)Feb 125 daysNotman DonaldChief Operating OfficerSSale−11.4K$9.04−$103.5K−3.0%366.4K after
Feb 17, 2026 (view filing)Feb 125 daysNayak SanjayChief Strategy OfficerSSale−10.3K$9.04−$93.5K−3.0%332.4K after10b5-1
Feb 17, 2026 (view filing)Feb 125 daysDugel PravinSee RemarksSSale−124.9K$9.04−$1.13M−4.0%3.03M after10b5-1
Feb 17, 2026 (view filing)Feb 125 daysWaheed NadiaChief Medical OfficerSSale−7.86K$9.04−$71.1K−2.4%318.4K after10b5-1
Feb 4, 2026 (view filing)Feb 2-42 daysNotman DonaldChief Operating OfficerSSale−11.5K$8.82−$101.4K−3.0%377.8K after2 lots
Nov 26, 2025 (view filing)Nov 242 daysNayak SanjayChief Strategy OfficerSSale−1.88K$12.04−$22.6K−0.7%277.9K after10b5-1
Nov 26, 2025 (view filing)Nov 242 daysDugel PravinSee RemarksSSale−19.5K$12.04−$235.1K−0.6%3.16M after10b5-1
Nov 26, 2025 (view filing)Nov 242 daysKaiser PeterChief Development OfficerSSale−3.01K$12.02−$36.1K−1.5%191.4K after10b5-1
Nov 26, 2025 (view filing)Nov 242 daysHeier Jeffrey S.Chief Scientific OfficerSSale−3.47K$12.04−$41.8K−1.4%245.9K after10b5-1
Nov 7, 2025 (view filing)Nov 52 daysSaroj NamrataChief Business OfficerSSale−25.9K$10.74−$277.8K−12.9%174.1K after10b5-1
Oct 10, 2025 (view filing)Oct 82 daysAnderman ToddChief Legal OfficerSSale−11.1K$12.34−$137.4K−11.3%87.6K after10b5-1
Oct 6, 2025 (view filing)Oct 24 daysKaiser PeterChief Development OfficerSSale−9.65K$11.03−$106.5K−4.7%194.4K after10b5-1
Oct 6, 2025 (view filing)Oct 24 daysHeier Jeffrey S.Chief Scientific OfficerSSale−10.5K$11.04−$115.9K−4.0%249.4K after10b5-1
Sep 4, 2025 (view filing)Sep 22 daysNotman DonaldSee RemarksSSale−1.07K$12.43−$13.3K−0.3%308.8K after
Aug 27, 2025 (view filing)Aug 252 daysKaiser PeterChief Development OfficerSSale−3.01K$12.04−$36.3K−1.5%204.1K after10b5-1
Aug 27, 2025 (view filing)Aug 252 daysNayak SanjayChief Strategy OfficerSSale−1.89K$12.04−$22.7K−0.7%279.7K after10b5-1
Aug 27, 2025 (view filing)Aug 252 daysHeier Jeffrey S.Chief Scientific OfficerSSale−3.06K$12.04−$36.9K−1.2%259.9K after10b5-1
Aug 27, 2025 (view filing)Aug 252 daysDugel PravinSee RemarksSSale−21.5K$12.04−$258.8K−0.7%3.23M after10b5-1
Jun 3, 2025 (view filing)Jun 21 dayWaheed NadiaChief Medical OfficerSSale−13.9K$8.05−$111.6K−6.3%206.8K after10b5-1
May 27, 2025 (view filing)May 234 daysNayak SanjayChief Strategy OfficerSSale−1.86K$7.17−$13.4K−0.7%281.6K after10b5-1
May 27, 2025 (view filing)May 234 daysKaiser PeterChief Development OfficerSSale−2.97K$7.17−$21.3K−1.4%207.1K after10b5-1
May 27, 2025 (view filing)May 234 daysHeier Jeffrey S.Chief Scientific OfficerSSale−3.02K$7.18−$21.7K−1.1%263.0K after10b5-1
May 27, 2025 (view filing)May 234 daysDugel PravinSee RemarksSSale−21.2K$7.18−$152.4K−0.6%3.50M after10b5-1
May 12, 2025 (view filing)May 84 daysLindstrom Richard L MDDirectorPPurchase+10.0K$6.96+$69.6K+6.1%172.7K after
Feb 26, 2025 (view filing)Feb 242 daysDugel PravinSee RemarksSSale−21.5K$6.87−$147.5K−0.6%3.52M after10b5-1
Feb 26, 2025 (view filing)Feb 242 daysHeier Jeffrey S.Chief Scientific OfficerSSale−3.06K$6.87−$21.0K−1.1%266.0K after10b5-1
Feb 26, 2025 (view filing)Feb 242 daysKaiser PeterChief Development OfficerSSale−3.01K$6.87−$20.7K−1.4%210.1K after10b5-1
Feb 26, 2025 (view filing)Feb 242 daysNayak SanjayChief Strategy OfficerSSale−1.90K$6.84−$13.0K−0.7%283.5K after10b5-1
Feb 4, 2025 (view filing)Jan 31-Feb 44 daysNotman DonaldSee RemarksSSale−17.4K$7.82−$136.2K−8.3%193.4K after2 lots
Nov 27, 2024 (view filing)Nov 252 daysHeier Jeffrey S.Chief Scientific OfficerSSale−2.95K$9.01−$26.6K−1.1%269.1K after10b5-1
Nov 27, 2024 (view filing)Nov 252 daysKaiser PeterChief Development OfficerSSale−2.90K$9.01−$26.1K−1.3%213.1K after10b5-1
Nov 27, 2024 (view filing)Nov 252 daysNayak SanjayChief Strategy OfficerSSale−1.81K$9.00−$16.3K−1.0%174.4K after10b5-1
Nov 27, 2024 (view filing)Nov 252 daysDugel PravinSee RemarksSSale−20.7K$9.01−$186.3K−2.5%791.8K after10b5-1
Aug 27, 2024 (view filing)Aug 234 daysNayak SanjayChief Strategy OfficerSSale−1.83K$9.02−$16.5K−1.0%176.2K after10b5-1